TP53 and neoplasm: ZMC-1 restored site-specific DNA binding and upregulation of p53 target genes (p21, Puma, Mdm2) (41), and inhibited mouse xenograft tumor growth with high allele-specificity for the p53-R175H (p53-R172 in mice) mutant.